| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | 1 | 3 | 2 | — | — | — | 1 | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 5.46 |
—
—
—
|
| 2025 | 4.63 |
—
—
—
—
|
| 2024 | 8.74 |
—
—
—
—
|
| 2023 | 8.34 |
—
—
—
—
|
| 2022 | 7.94 |
—
—
—
—
|
| 2021 | 7.54 |
—
—
—
—
|
| 2020 | 7.26 |
—
—
—
—
|
| 2019 | 6.72 |
—
—
—
—
|
| 2018 | 5.97 |
—
—
—
—
—
|
| 2017 | 5.31 |
—
—
—
—
|
| 2016 | 4.75 |
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 8,095.00 | 10,292.00 | 12,930.00 | 9,196.00 |
| Receivables | 7,530.00 | 7,247.00 | 7,621.00 | 8,337.00 |
| Inventory | 6,178.00 | 5,884.00 | 6,162.00 | 6,401.00 |
| Other | 1,699.00 | 2,624.00 | 3,674.00 | 4,145.00 |
| 23,502.00 | 27,908.00 | 30,387.00 | 28,079.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 6,849.00 | 6,109.00 | 6,315.00 | 6,390.00 |
| ST’ Debt | 1,796.00 | 1,325.00 | 1,546.00 | 5,282.00 |
| Other | — | 408.00 | 1,198.00 | 1,275.00 |
| 18,539.00 | 21,256.00 | 23,414.00 | 23,194.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9,143.00 | 9,719.00 | — | — |
—
|
| ’25 | 8,925.00 | 9,322.00 | 10,408.00 | 8,787.00 |
37,442.00
|
| ’24 | 9,105.00 | 9,577.00 | 9,728.00 | 6,307.00 |
34,717.00
|
| ’23 | 8,864.00 | 9,146.00 | 9,212.00 | 5,787.00 |
33,009.00
|
| ’22 | 8,376.00 | 8,953.00 | 8,951.00 | 9,186.00 |
35,466.00
|
| ’21 | 8,454.00 | 8,808.00 | 8,473.00 | 8,657.00 |
34,392.00
|
| ’20 | 8,463.00 | 7,477.00 | 7,797.00 | 8,900.00 |
32,637.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (650.00) | 1,276.00 | — | — |
—
|
| ’25 | 597.00 | 1,319.00 | 3,288.00 | 1,204.00 |
6,408.00
|
| ’24 | 448.00 | 1,371.00 | 1,997.00 | 2,281.00 |
6,097.00
|
| ’23 | (784.00) | 1,360.00 | 1,809.00 | 2,955.00 |
5,340.00
|
| ’22 | 36.00 | 789.00 | 2,083.00 | 2,366.00 |
5,274.00
|
| ’21 | 978.00 | 1,278.00 | 1,119.00 | 2,663.00 |
6,038.00
|
| ’20 | 939.00 | 1,480.00 | 1,007.00 | 2,782.00 |
6,208.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (873.00) | 961.00 | — | — |
—
|
| ’25 | 407.00 | 1,093.00 | 2,799.00 | 1,154.00 |
5,453.00
|
| ’24 | 215.00 | 1,112.00 | 1,718.00 | 2,181.00 |
5,226.00
|
| ’23 | (966.00) | 1,129.00 | 1,568.00 | 2,911.00 |
4,642.00
|
| ’22 | (137.00) | 632.00 | 1,899.00 | 2,143.00 |
4,537.00
|
| ’21 | 771.00 | 1,093.00 | 915.00 | 2,391.00 |
5,170.00
|
| ’20 | 807.00 | 1,253.00 | 768.00 | 2,531.00 |
5,359.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.58 | 16.65 | — | — |
—
|
| ’25 | 4.44 | 4.90 | 5.72 | 0.92 |
15.98
|
| ’24 | 4.46 | 4.72 | 4.32 | 3.92 |
17.42
|
| ’23 | 4.14 | 4.44 | 4.54 | 3.82 |
16.94
|
| ’22 | 3.28 | 3.68 | 4.56 | 3.02 |
14.54
|
| ’21 | 4.06 | 4.08 | 3.60 | 4.10 |
15.82
|
| ’20 | 4.42 | 3.06 | 2.14 | 3.82 |
13.44
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 164.71 | 172.86 | 187.47 | 177.29 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 219.33 | 214.72 | 239.97 | 238.93 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 97,000 | 95,000 | 102,000 | 101,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.37 | 0.35 | 0.34 | 0.37 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35,466.00 | 33,009.00 | 34,717.00 | 37,442.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.99% | 37.48% | 38.47% | 36.93% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,379.00 | 6,191.00 | 6,244.00 | 5,476.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.99% | 18.76% | 17.99% | 14.63% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,966.00 | 5,672.00 | 5,740.00 | 4,772.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,204.00 | 1,004.00 | 1,152.00 | 2,112.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 104.76 | 99.57 | 106.67 | 117.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.66 | 17.06 | 17.52 | 16.08 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.58 | 16.11 | 18.73 | 20.06 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.18) | (2.11) | (2.68) | (2.99) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.40 | 14.00 | 16.06 | 17.07 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.16 | 49.57 | 58.85 | 47.04 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 338.55 | 331.50 | 325.45 | 319.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.43 | 12.10 | 12.74 | 12.74 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.02 | 2.07 | 2.09 | 1.75 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.14 | 4.17 | 3.79 | 4.35 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.21 | 2.39 | 2.57 | 2.17 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.29 | 16.96 | 17.06 | 14.88 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,274.00 | 5,340.00 | 6,097.00 | 6,408.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (737.00) | (698.00) | (871.00) | (955.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,537.00 | 4,642.00 | 5,226.00 | 5,453.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,044.00 | 4,963.00 | 6,652.00 | 6,973.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16,853.00 | 18,358.00 | 26,765.00 | 28,687.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,743.00 | 10,263.00 | 16,473.00 | 15,757.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17,319.00 | 16,434.00 | 19,154.00 | 15,030.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.84% | 9.14% | 8.35% | 6.35% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.69% | 14.30% | 11.70% | 11.86% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.17% | 33.53% | 32.06% | 27.67% | — | — | — |
ROE
|
Honeywell International (HON) exemplifies a resilient conglomerate, with diversified segments in aerospace, building technologies, and safety solutions driving steady recovery from COVID disruptions. Revenue fell 11% in 2020 but rebounded to $38.5 billion in 2024, with projections showing modest 3% growth in 2025 followed by 6% annually through 2027. Operational efficiency stands out, as revenue per employee rose 26% to $377,000 amid headcount discipline, while gross margins expanded from 29.6% to 38.1%, bolstering profitability in a capital-intensive sector.
Free cash flow per share has strengthened to $8.53, funding robust buybacks (15% share reduction), dividends (Dividend King status), and targeted investments, though total debt doubled to $28.7 billion, lifting net debt and pressuring ROIC to 12.6%. EPS is forecasted to grow 11-10% into 2026-2027, supporting a reasonable valuation at 24x P/E and 3.6x sales, with the stock up 140% over the decade despite lagging some peers. Insider selling adds short-term caution, but analyst targets suggest stable potential amid efficiency gains.
For risk-averse investors, HON offers a cash-fortified balance sheet and 10%+ EPS upside, buffered by 15% ROE—yet debt leverage and cyclical aerospace risks warrant vigilance. Fundamentals point to a steady compounder with rerating potential on dips.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.